The Effect of a Safety Video on Ski and Snowboard School Program Participants in Calgary, Alberta

October 4, 2017 updated by: Sport Injury Prevention Research Centre

Ski and Snowboard School Programs: Assessing the Effect of a Safety Video Intervention on Knowledge, Behaviour and Injury Risk in Youth Skiing and Snowboarding

The main objective of the study is to investigate if a video intervention can help increase knowledge, decrease risky behaviours on the hill, and reduce injury risk in students who participate in ski and snowboard school programs. The study design is a cluster randomized controlled trial where participating schools will be randomized into either an intervention or control group. The intervention video will contain an injury prevention and safety promotion component for skiing or snowboarding. The control group will receive the standard orientation video that many schools typically provide for students prior to their ski/snowboard outings in previous years.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Unknown

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Skiing and snowboarding are two popular winter activities, and school sanctioned ski and snowboard programs hosted at local ski areas provide students the opportunity to discover and engage in new activities that can benefit their physical and mental well-being. However, these winter sports can be associated with a high risk of injury. Previous studies have found that the majority of injuries in snow sports are preventable and tend to be caused by poor decisions, actions and human error. As part of ski and snowboard school programs at WinSport's Canada Olympic Park (COP) in Calgary, Alberta, children receive an introduction to the sport including basic safety information. However, there is no consistent and comprehensive injury prevention component built into ski and snowboard school outing programs. For this research, the investigative team will implement and evaluate a video intervention with built-in injury prevention and safety promotion messages.

The study design is a cluster randomized controlled trial where participating schools will be randomized into either an intervention or control group. The intervention video is approximately 10 minutes in length and will include information on proper preparation, correct protective equipment use, and strategies for speed control and collision avoidance while skiing or snowboarding. The content and format of the intervention video was developed and informed by focus groups with parents, students, ski patrollers, and ski instructors to ensure optimal information uptake for viewers.The control group will receive the standard orientation video that many schools usually provide for students prior to their ski/snowboard outings.

The participants will be children between the ages of 6 to 15 years (grades 1 to 9) who participate in the ski and snowboard school programs at COP in Calgary, Alberta. The outcomes of interest that will be measured include knowledge uptake (through the use of pre- and post-test questionnaires delivered before and after watching the assigned video, and measuring differences in test scores before and after watching the video), behavioural changes (through the use of multiple observers who will collect data on unsafe behaviours and actions observed on the ski hill during two hour time intervals) and injury risk (through the use of nationally standardized ski patrol accident report forms that will be provided by the ski area and school program enrollment data to calculate injury rates).

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
2348

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

6 years to 15 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Elementary and junior high school students (grades 1 to 9)
  • Attends a school participating in a ski and snowboard school program hosted by a local ski area

Exclusion Criteria:

  • High school students (grade 10 or above)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Intervention
The intervention group will receive an educational video containing safety messages and an injury prevention component with the intent of reducing behaviours and actions on the hill than can potentially lead to injury.
Other: Ski and Snowboard Safety Video
The ski and snowboard safety video (~10 minutes) includes information on preparation, correct protective equipment use (e.g. helmets), and strategies for speed control and collision avoidance. Focus groups were conducted among parents, students, ski patrol, and ski instructors to inform the content and format of the video. Feedback and suggestions from focus groups were utilized to ensure that the video optimized information uptake from children and adolescents who watch the video. The Health Action Process Approach (HAPA) model was embedded throughout the video to ensure evidence-informed pathways towards positive behaviour change.
No Intervention: Control
The control group will receive the usual procedures associated with school outings where students have the opportunity to watch the standard welcome video (~8 minutes) with information on how their day will go and how to use and put on safety equipment. The information given in the control procedure emphasizes preparation and how to use and put on equipment rather than safety messages oriented towards preventing injury and collisions. Students in the control group will watch the video prior to participating in the ski area school program.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Knowledge Uptake
Time Frame: Throughout the ski/snowboard season (up to 5 months)

Students will take a baseline safety knowledge assessment before watching the assigned video (pre-test) and take the same test immediately after watching the assigned video (post-test). The video viewing and the pre- and post-test completion will be moderated in a classroom by the teacher and a member of the research team. Questions about preparations, equipment and proper hill etiquette will be included in the knowledge assessment questionnaire.

At the start of the data collection session at the school, demographic information will be collected followed by the pre-test knowledge assessment for students to complete independently. After the pre-test knowledge assessment is completed and submitted, the students will then watch their assigned video. Immediately following the video, the students will independently complete the post-test knowledge assessment. A follow-up assessment test will be given to the participants approximately 1 month after watching the video.
Throughout the ski/snowboard season (up to 5 months)

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Risky Behaviours
Time Frame: Throughout the ski/snowboard season (up to 5 months)
Two research assistants (RAs) will observe the behaviour and characteristics of school participants during 2-hour intervals. Data will be collected on multiple unsafe behaviours, including: obstructing the run, stopping in an area where they are not visible, not yielding or giving right of way to skiers/snowboarders below, skiing/snowboarding too close to others, excessive speed, and jumping unsafely. RAs will select and agree on the next student who comes off the magic carpet to observe. When both observers are ready, they will give each other a cue and start observing the same student as they go down the hill. The RAs will stop observing and recording data on that student when the student reaches the bottom of the run. Once both RAs have recorded their data and confirm they are ready for the next student, they will choose the next student for observation. The number of students in the ski area during the time periods will also be recorded for denominator data as students per hour.
Throughout the ski/snowboard season (up to 5 months)
Injury
Time Frame: Throughout the ski/snowboard season (up to 5 months)
Injury data will be obtained from the ski patrol Accident Report Forms (ARF). ARFs are completed by ski patrollers and contain information on the circumstances surrounding the injury, as well as the demographic characteristics of the injured skier or snowboarder. The forms also include information on whether those who were injured were participating in a school program at the time of injury. All personal identifying information will be removed from ARFs by ski patrol before being given to the research team for analysis. The name of the school and the date and time of the injury will be used to link ski patrol ARF injury data to the intervention or control schools. Denominator data will be the school program data; these data contain information on which schools were at the ski area for each day and the number of participants. This information is entered by school teachers and compiled by WinSport.
Throughout the ski/snowboard season (up to 5 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Sport Injury Prevention Research Centre

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Brent E Hagel, PhD, University of Calgary

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
July 26, 2016

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
March 17, 2017

Study Completion (Anticipated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 30, 2017

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
May 2, 2017

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 10, 2017

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 14, 2017

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
October 5, 2017

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
October 4, 2017

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
April 1, 2017

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • REB15-0749

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Risk Behavior

Clinical Trials on Ski and Snowboard Safety Video

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings